-
-
-
-
-
-
-
Teladoc (TDOC) Misses Q3 EPS by 2c, provides guidance
-
-
-
-
-
-
-
Teladoc Health Reports Second Quarter 2025 Results
-
-
-
-
-
-
-
Given contract opportunity Caid stocks likely undervalued, says Cantor Fitzgerald
-
-
-
-
-
-
-
Teladoc (TDOC) PT Lowered to $8 at Jefferies
-
-
-
-
-
-
-
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Teladoc
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Teladoc, Cambium, Enphase, and Fat Brands and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
TDOC INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Teladoc Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
-
1,199,626 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

